https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-11-14 / Trends Cancer 2024 Jan;10(1):8-11
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-11-14 / Trends Cancer 2024 Jan;10(1):8-112023-11-14 00:00:002023-11-14 00:00:00Targeting immunogenic cell death for glioma immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-11-12 / Med Oncol 2023 Nov;40(12):354
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-11-12 / Med Oncol 2023 Nov;40(12):3542023-11-12 00:00:002023-11-12 00:00:00Therapeutic cell-based vaccines for glioblastoma multiforme
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2023-11-07 17:20:492024-01-18 12:04:25Neue IOZK Veröffentlichung zum Thema Liquid Biopsy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-11-06 / Cureus 2023 Nov;15(11):e48412
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-11-06 / Cureus 2023 Nov;15(11):e484122023-11-06 00:00:002023-11-06 00:00:00Radioimmunotherapy With WT1 Dendritic Cell Vaccine for End-Stage Lung Adenocarcinoma Markedly Shrinks Tumors
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-11-01 / Immun Inflamm Dis 2023 Nov;11(11):e1099
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-11-01 / Immun Inflamm Dis 2023 Nov;11(11):e10992023-11-01 00:00:002025-09-04 17:02:01The DC-T cell axis is an effective target for the treatment of non-small cell lung cancer
